Drug Profile
Esonarimod
Alternative Names: KE 298; SonatimodLatest Information Update: 12 Mar 2008
Price :
$50
*
At a glance
- Originator Taisho Pharmaceutical
- Class Antirheumatics; Carboxylic acids; Small molecules
- Mechanism of Action Interleukin 1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Rheumatoid arthritis